A Novel microRNA and transcription factor mediated regulatory network in schizophrenia
© Guo et al; licensee BioMed Central Ltd. 2010
Received: 30 September 2009
Accepted: 15 February 2010
Published: 15 February 2010
Schizophrenia is a complex brain disorder with molecular mechanisms that have yet to be elucidated. Previous studies have suggested that changes in gene expression may play an important role in the etiology of schizophrenia, and that microRNAs (miRNAs) and transcription factors (TFs) are primary regulators of this gene expression. So far, several miRNA-TF mediated regulatory modules have been verified. We hypothesized that miRNAs and TFs might play combinatory regulatory roles for schizophrenia genes and, thus, explored miRNA-TF regulatory networks in schizophrenia.
We identified 32 feed-forward loops (FFLs) among our compiled schizophrenia-related miRNAs, TFs and genes. Our evaluation revealed that these observed FFLs were significantly enriched in schizophrenia genes. By converging the FFLs and mutual feedback loops, we constructed a novel miRNA-TF regulatory network for schizophrenia. Our analysis revealed EGR3 and hsa-miR-195 were core regulators in this regulatory network. We next proposed a model highlighting EGR3 and miRNAs involved in signaling pathways and regulatory networks in the nervous system. Finally, we suggested several single nucleotide polymorphisms (SNPs) located on miRNAs, their target sites, and TFBSs, which may have an effect in schizophrenia gene regulation.
This study provides many insights on the regulatory mechanisms of genes involved in schizophrenia. It represents the first investigation of a miRNA-TF regulatory network for a complex disease, as demonstrated in schizophrenia.
Schizophrenia is a complex, chronic and severe brain disorder. So far, its pathophysiology and molecular mechanisms have remained poorly understood . In the last decade numerous linkage and association studies, including a few genome-wide association studies (GWAS), have been performed to identify genetic predispositions to the disease, but most studies have been inconclusive. The limited success in the detection of genetic factors led us to hypothesize that schizophrenia is likely caused by the altered expression of many genes, which may individually contribute only a small risk, but may in aggregate interact at the biological pathway or gene-network level.
Recently, patterns of differential gene expression have been identified between schizophrenia case and control samples [2, 3]. MicroRNAs (miRNAs) and transcription factors (TFs) are main regulators of gene expression. MiRNAs are short endogenous noncoding RNAs that mediate post transcriptional regulation and regulate a wide range of biological processes and diseases [4, 5]. In the nervous system, studies have reported involvement of miRNAs in brain development, neuronal differentiation, and synaptic plasticity, all processes that have been implicated in neurological syndromes such as schizophrenia, fragile × syndromes, Parkinson's disease and Huntington's disease . Specifically, 18 miRNAs were recently found to be differentially expressed in post-mortem brain samples of schizophrenia patients and controls [6, 7]. Interestingly, a case-control association study revealed that two single nucleotide polymorphisms (SNPs) in miRNAs hsa-miR-206 and hsa-miR-198 were significantly associated with schizophrenia . Furthermore, brain miRNAs affected by a microdeletion syntenic to human 22q11.2 were found in mouse models and human individuals carrying this microdeletion are at high risk of developing schizophrenia . It has also been reported that miRNA hsa-miR-195 regulates BDNF and alters the expression of downstream GABAergic transcripts in schizophrenia . Most recently, studies found that a miRNA regulates signaling downstream from the NMDA receptor, suggesting miRNAs as a new mechanism for altering brain gene expression in schizophrenia [11, 12]. This accumulating data suggests that miRNAs may play important roles in the expression of genes linked to schizophrenia.
Transcription factors are essential regulators of gene expression in all living organisms. A TF regulates transcription of its target gene by specifically binding to the transcription factor binding site (TFBS) in the gene's promoter region. Since expression of an miRNA may be regulated by a TF , TF and miRNA may reciprocally regulate one another to form feedback loops, or alternatively, both TF and miRNA may regulate their target genes and form feed-forward loops (FFLs). Two recent studies explored hundreds of potential miRNA-mediated feedback and feed-forward loops at the genome level in mammals and found some interesting regulatory motifs [14, 15]. Besides, Martinez et al.  combined experimental and computational methods and identified 23 miRNA-TF composite feedback loops in C. elegans. Several feedback loops and FFLs have been experimentally verified in mammals, such as feedback loops between ZEB1/SIP1 and miR-200 family in embryological development, E2Fs and miR-17/20 in cellular apoptosis, PITX3 and miR-133b in midbrain dopamine neurons, and a FFL E2Fs-Myc-miR-17/20 [17–19]. These studies were performed at the whole genome level by a computational approach or for specific FFLs by experimental validation, rather than a comprehensive miRNA-mediated network analysis for a specific complex disease or tissue.
In this study, we explored miRNA-TF regulatory networks in schizophrenia. Among schizophrenia candidate genes (SZGenes), we identified the potential targets of TFs and schizophrenia related miRNAs. These datasets and their regulations were used for miRNA-mediated feedback and feed-forward loop analysis. We revealed some schizophrenia related miRNA-TF regulatory modules and constructed a converged miRNA-TF regulatory network in which EGR3 and hsa-miR-195 served as core regulators. By combining miRNA-TF network analysis and literature survey, we proposed a pathway model highlighting EGR3 and miRNAs involving in the signal transduction and regulatory pathways in schizophrenia.
miRNAs and TFBSs
Location and conservation information of schizophrenia related miRNAs
Location (Chr: start-end [strand])
3: 52277334-52277417 [-]
7: 99529552-99529633 [-]
1: 197094625-197094734 [-]
9: 126495810-126495898 [+]
17: 6861658-6861744 [-]
3: 121597205-121597266 [-]
6: 52117106-52117191 [+]
X: 133131505-133131573 [-]
17: 1900315-1900424 [-]
9: 96888124-96888191 [+]
19: 13808101-13808173 [-]
2: 218975613-218975689 [+]
7: 130212046-130212109 [-]
7: 130212758-130212838 [-]
1: 206042411-206042491 [-]
1: 206041820-206041907 [-]
6: 72169975-72170045 [-]
8: 135881945-135882032 [-]
8: 135886301-135886370 [-]
1: 40992614-40992705 [+]
9: 85774483-85774592 [-]
15: 86956060-86956169 [+]
19: 4721682-4721791 [+]
1: 154656757-154656845 [-]
5: 87998427-87998513 [-]
15: 87712252-87712341 [+]
13: 90801569-90801646 [+]
X: 133131234-133131308 [-]
1: 153431592-153431687 [+]
To test whether we observed more SZmiRNA targets in the 160 SZGenes, we ran a permutation to count the number of targets of each SZmiRNA in 160 randomly selected genes, and repeated this process 10,000 times. Most (25 of 29, 86.2%) of SZmiRNAs had a significantly larger number of targets in SZGenes than randomly selected genes (t-test, p-value < 0.001), while hsa-miR-206 had fewer targets in SZGenes and the difference for 3 miRNAs in hsa-miR-7 family was not significant (see Additional file 2: Fig. S1).
Using stringent criteria (Z score >2.33 in UCSC Genome Browser) and conservation among the human, mouse and rat genomes, we obtained 517 TFBSs in the promoter regions of 115 of the 160 SZGenes and 184 TFBSs in the promoter regions of 18 of the 29 SZmiRNAs. Among the 115 SZGenes, 79 (68.7%) had fewer than 5 TFBSs and 10 (8.7%) had more than 10 TFBSs. Among the SZmiRNAs, hsa-miR-212 and hsa-miR-195 had more than 20 TFBSs (see Additional file 2: Fig. S2). These observations seemed to reflect a complex regulation of schizophrenia related genes, TFBSs and miRNAs.
Feed-forward loops (FFLs) in schizophrenia
FFLs among TFBSs, SZmiRNAs and schizophrenia genes (SZGenes)
EGR1, EGR2, EGR3, EGR4
EGR1, EGR2, EGR3, EGR4
EGR1, EGR2, EGR3, EGR4
EGR1, EGR2, EGR3, EGR4
EGR1, EGR2, EGR3, EGR4
V$CREB_01, V$CREBP1CJUN_01, V$CREBP1_Q2
EGR1, EGR2, EGR3, EGR4
Statistics of FFLs identified by miRNAs among four schizophrenia gene lists
No. of miRNAs
1.80 × 10-5
9.86 × 10-3
4.79 × 10-5
2.97 × 10-7
Secondly, we ran 10,000 random simulations (see Methods). In each run, since there were 209 miRNA target pairs between SZmiRNAs and SZGenes, we randomly selected 209 miRNA target pairs out of all target pairs of the 29 SZmiRNAs and calculated the number of FFLs among TFBSs, SZmiRNAs and those randomly selected target genes. We calculated a p value = 0.0009, indicating that our observed FFLs differed significantly from chance.
miRNA and TF regulatory network in schizophrenia
Subnetworks for core genes in the miRNA-TF regulatory network
There were 5 core genes (EGR3, hsa-miR-195, hsa-miR-20b, hsa-miR-9-3 and GRM7) in the miRNA-TF regulatory network (Figure 3) according to the definition in the Methods section. We extracted subnetworks for these 5 core genes by including the core genes and their directly linked molecules in the miRNA-TF regulatory network (see Additional file 2: Fig. S3). In this subnetwork analysis, EGR3 stood out as a promising gene and regulator. As a gene, it is regulated by 5 TFs and 4 SZmiRNAs, while in its capacity as a TF, it regulates 3 SZGenes and 3 SZmiRNAs. EGR3 is the only gene in the network that links to all 4 of the other core genes.
Pathways enriched among the targets of 3 core miRNAs
Enriched pathway of miRNA targetsa
3.98 × 10-5
Axonal guidance signaling
1.35 × 10-4
2.04 × 10-4
BMP signaling pathway
3.47 × 10-4
7.59 × 10-4
Protein ubiquitination pathway
9.12 × 10-4
1.55 × 10-3
1.86 × 10-3
2.00 × 10-3
B cell receptor signaling
3.72 × 10-3
Inositol phosphate metabolism
4.57 × 10-3
4.79 × 10-3
Reelin signaling in neurons
4.79 × 10-3
Synaptic long term potentiation
7.08 × 10-3
7.59 × 10-3
Ephrin receptor signaling
7.59 × 10-3
Insulin receptor signaling
9.12 × 10-3
Cell cycle: G1/S checkpoint regulation
1.10 × 10-4
Reelin signaling in neurons
2.75 × 10-4
B cell receptor signaling
3.55 × 10-4
Axonal guidance signaling
4.17 × 10-4
5.50 × 10-4
1.12 × 10-3
Semaphorin signaling in neurons
1.29 × 10-3
1.35 × 10-3
Hypoxia signaling in the cardiovascular system
2.04 × 10-3
3.24 × 10-3
3.89 × 10-3
3.98 × 10-3
Cell cycle: G2/M DNA damage checkpoint regulation
5.75 × 10-3
Circadian rhythm signaling
6.03 × 10-3
Ephrin receptor signaling
6.03 × 10-3
Factors promoting cardiogenesis in vertebrates
7.41 × 10-3
7.41 × 10-3
7.59 × 10-3
8.71 × 10-3
1.58 × 10-4
Regulation of actin-based motility by Rho
2.88 × 10-3
3.72 × 10-3
Axonal guidance signaling
3.89 × 10-3
Ephrin receptor signaling
4.17 × 10-3
Fcγ receptor-mediated phagocytosis in macrophages and monocytes
6.31 × 10-3
SNPs on miRNA target sites, TFBSs, and miRNA genes
SNPs on miRNA target sites and TFBSs have been associated with many complex diseases [4, 25, 26]. So far, most of the SNPs associated with schizophrenia have not been in exonic regions . Thus, it is important to examine SNPs in these schizophrenia related miRNA genes and their target sites and TFBSs. We identified 7 SNPs on the SZmiRNA target sites of 7 SZGenes, 14 SNPs on TFBSs of 13 SZGenes and 5 SNPs on TFBSs of 5 SZmiRNAs. Moreover, we found 4 SNPs in pre-SZmiRNAs and 18 SNPs in the expanded regions (100 bp each side) of pre-SZmiRNAs including one SNP (rs41283391) located 46 bp upstream of hsa-miR-195 pre-miRNA (see Additional file 3).
There were two publicly available GWA studies (CATIE and GAIN) for schizophrenia, neither of which has yet been successful in identifying significant genome-level markers . Surprisingly, all of these SNPs except one (rs1700 in hsa-miR-198), were not included in either GWAS marker set. We found two potential regulatory SNPs in GRM7, one of the five core genes. These two SNPs were located on TFBS (V$AHRARNT_01, SNP rs62237229) and miRNA target site (hsa-miR-20b, SNP rs56173829). Both V$AHRARNT_01 and hsa-miR-20b were included in our FFLs. Our literature search revealed that these SNPs and sites have not been studied for schizophrenia. Further experimental verification is warranted.
Online access of miRNAs and their targets in schizophrenia genes
We deposited all miRNAs complied in this study and their potential targets in schizophrenia genes into S chiz ophrenia G ene R esource (SZGR), a comprehensive online resource including genetic and biological data for schizophrenia genes . SZGR deposits genetic data from all available sources including association studies, linkage scans, gene expression, literature, GO annotations, gene networks, pathways, and miRNAs and their target sites. Moreover, SZGR provides online tools for data browsing and searching, data integration, custom gene ranking, and graphical presentation.
Potential regulatory networks in schizophrenia
We performed an exploratory miRNA-TF mediated regulatory network analysis, identifying some promising FFLs and mutual feedback loops in schizophrenia. In the converged network, we identified 5 core genes including EGR3 and hsa-miR-195 that likely play important regulatory roles. The network also includes some well-studied schizophrenia candidate genes (e.g., BDNF, DRD2, GRIN1 and GAD1). Although this investigation started from experimentally verified schizophrenia-related miRNAs, miRNA-TF-gene regulations, and a set of schizophrenia candidate genes prioritized by multiple lines of genetic evidence, most of the miRNA targets and TFBSs used in this study are putative and not error-free. At present, miRNAs have not been well tested for association with schizophrenia. The number of schizophrenia related miRNAs is expected to be greater than what we compiled. However, our analysis and subsequent permutation tests indicated that our regulatory network is nonrandom in the whole molecular network. The identified network modules provide potential targets for follow-up experimental verification, and provide important insights into the etiology of schizophrenia. We discuss some potential pathways below.
EGR3 encodes a zinc finger transcription factor and plays important roles in cellular growth, environmental stimuli, muscle-spindle development and neuronal development . In neuronal development, EGR3 is required for normal terminal axon extension and branching, sympathetic target tissue innervation and function, and hippocampus-dependent learning and memory processing [30, 31]. EGR3 indirectly modulates synaptic plasticity through its regulation of the ARC gene, a synaptic activity-induced effector molecule . In developing neurons and epilepsy, BDNF is the endogenous signal that induces EGR3 expression via a PKC/MAPK-dependent pathway, and then EGR3 up-regulates the expression of GABRA4 by binding its promoter [33, 34]. EGR3 is required in mediating the response to stress and novelty . EGR3 has been reported to be associated with schizophrenia in both case-control and family-based studies and its expression has been shown to be decreased in schizophrenia patients [36, 37]. Mice lacking EGR3 and schizophrenia patients display a similar decreased susceptibility to the side effects of antipsychotic medications . These studies consistently suggest an important role for EGR3 in neuron activity and schizophrenia.
Moreover, EGR3 is a downstream gene of many signaling pathways including pathways triggered by NGF, BDNF and NRG1 [30, 34, 39, 40], of which BDNF and NRG1 are schizophrenia susceptibility genes. Both EGR1 and EGR2 are induced by BDNF signaling in primary cortical neurons  and EGR3 has been proved to be a target gene of EGR1 . EGR3 and EGR1 directly regulate the expression of NGFR (p75NTR) , a receptor of all neurotrophins, including NGF and BDNF. Interestingly, NGFR is involved in the regulation of axonal elongation  and EGR3 shares a similar function . EGR3 is regulated by the calcium-responsive protein phosphatase calcineurin , which might be triggered by a calcium influx through NMDARs , whose activation also induces EGR3 mRNA expression . PPP3CC (encoding calcineurin catalytic γ subunit) is located very close to EGR3 on chromosome 8 and was reported to be associated with schizophrenia [37, 48]. Furthermore, the calcineurin/NFAT signaling pathway is required for neuronal development and axon growth, but it has little or no effect in neuron survival [49, 50]. Interestingly, EGR3 is also required for normal axon extension and branching, but not for neuron survival . Neurotrophins (NGF and BDNF) stimulate NFAT nuclear translocation and activation of NFAT-dependent transcription in cortical neurons . It has been proposed that some unknown factors involved in calcineurin/NFAT signaling induce axon growth [49, 50]. Based on these literature surveys and our miRNA-mediated regulatory network analysis, we propose that EGRs, especially EGR3, are key factors regulated by calcineurin/NFAT signaling in neuronal development. Moreover, in the immune system, NFAT directly transactivates EGR3 and EGR2, then activates the expression of FasL to trigger cell apoptosis .
Hsa-miR-195 might prove a promising miRNA in schizophrenia and nervous system
Hsa-miR-195 is a core miRNA potentially targeted by 6 TFs and also targeting 6 SZGenes in our network. It was reported significantly down-regulated in the prefrontal cortex of schizophrenia patients . So far, it has been the only miRNA whose regulation of schizophrenia genes has been verified by experimental evidence. It regulates BDNF, altering the expression of downstream GABAergic transcripts (NPY, SST and PV) in schizophrenia patients . Note that BDNF also affects GABAergic system as a mediator of EGR3-induced GABRA4 regulation in developing neurons . In our miRNA-mediated FFLs, EGR3 potentially regulates hsa-miR-195. Thus, hsa-miR-195, BDNF and EGR3 form a critical feedback regulatory loop (Figure 4). The predicted targets of hsa-miR-195 are enriched in neuron related pathways, such as axonal guidance signaling, reelin signaling in neurons, long term synaptic potentiation and Ephrin receptor signaling pathways (Table 4). In combination, the evidence above suggests that hsa-miR-195 might be a key miRNA in schizophrenia as well as nervous system.
Potential utilities of FFLs and miRNA-TF composite feedback loops
FFL is an important regulatory motif and has been found in organisms such as Escherichia coli, yeast and human . A traditional FFL is composed of two TFs and one target gene in gene expression regulation. Because miRNAs play key regulatory functions in gene expression, a FFL consisting of a TF, miRNA and a target gene is likely a powerful tool to investigate regulatory mechanisms of diseases at both the transcriptional and translational levels. It has been estimated that there are several thousands of human genes under this combinatory TF-miRNA regulation . At present, only a few FFLs have been experimentally verified. Some examples include E2Fs-Myc-miR-17/20 , E2F-miR-106b/93/25-CDK inhibitors  and PKC-MAPK-miR-15a . A miRNA-TF composite feedback loop is a direct regulation motif. Some experimental examples are ZEB1/SIP1 and the miR-200 family in embryologic development and Pitx3 and miR-133b in neuron development [17, 18]. In our miRNA-mediated network in schizophrenia, we found an interesting miRNA-TF loop, the miR181-ESR1 loop. ESR1 is the only TF in our network whose gene has positive association result for schizophrenia . Some SNPs in ESR1 were also found significantly associated with schizophrenia in our genotyping project (unpublished data). Additionally, Inoue et al.  suggested EGR3 being a target of ESR1 in breast cancer cells. Since EGR3 is a core gene in our miRNA-mediated schizophrenia network, this provides another link for ESR1 to schizophrenia.
We compiled schizophrenia related miRNAs to predict SZmiRNA-TF-SZGene FFLs and found significantly more SZmiRNA-related FFLs in schizophrenia candidate genes. This is the first study of miRNA-TF regulatory networks in schizophrenia. We revealed that EGR3 and hsa-miR-195 are critical in the schizophrenia regulatory network. EGR3 is at the convergence of several signaling pathways, miRNA regulatory networks, adaptation to stress, and genetic susceptibility to schizophrenia. Although this study is exploratory, it provides an alternative and, perhaps, an effective approach for studying the regulatory mechanisms of genes involved in schizophrenia.
Schizophrenia, brain expressed, and non-brain expressed miRNAs
We compiled schizophrenia related miRNAs (SZmiRNAs) from three studies: (1) 16 miRNAs differentially expressed in prefrontal cortex of schizophrenia patients from controls ; (2) 2 miRNAs differentially expressed in postmortem cortical tissues of schizophrenia patients from controls ; and (3) 2 miRNAs in which 2 SNPs were found associated with schizophrenia in case/control samples . For comparison, we compiled two control miRNA datasets: miRNAs expressed in brain (brain miRNAs) and non-brain tissues (non-brain miRNAs). Brain miRNAs were collected from miRNA microarray expression studies and a miRNA regulation survey study [7, 56, 57]. Non-brain miRNAs were collected from two large-scale miRNA expression atlas studies [58, 59]. After we manually checked these miRNAs, we removed SZmiRNAs from brain miRNAs and, similarly, brain miRNAs from non-brain miRNAs to avoid redundancy. We obtained information of genomic locations, host genes and conservation among species of these miRNAs from miRBase (Release 11.0, genome assembly: NCBI36) .
Schizophrenia candidate genes
We used a list of 160 schizophrenia candidate genes (SZGenes) prioritized by a multi-dimensional evidence-based prioritization approach . These genes were selected based on integrative evidence from linkage, association, gene expression and literature search. Our follow up evaluation using independent GWAS p-values and gene expression features suggested these genes were promising . Additionally, we compiled three other SZGene lists: (1) 270 genes having at least one positive association result in the SchizophreniaGene database (accessed in April 2008) , (2) 124 genes having at least two positive results in the SchizophreniaGene database, and (3) 75 SZGenes selected by a combined odds ratio method from association studies .
Target prediction of miRNAs and transcription factors
Among many miRNA target prediction programs, TargetScan had the best performance based on two large scale miRNA induced protein synthesis studies [63, 64]. We retrieved all the miRNA target prediction results from the TargetScan server (version 4.2, April 2008)  and then extracted the miRNA and target gene pairs by the corresponding miRNA lists (e.g., SZmiRNAs) and genes (e.g., SZGenes). Except one miRNA that is conserved only in primates (hsa-miR-198, Table 1), we required the miRNA target sites to be conserved in mammals. Although SZGenes tend to be longer , the length of the 3' untranslated regions (UTRs) in which target sites were predicted, was not found significantly different between the SZGenes and the other human genes (Wilcoxon test, p = 0.09). To examine whether SZmiRNAs have more miRNA targets in SZGenes than in non-SZGenes, we randomly selected the same number of genes from the human protein-coding genes and then counted the number of targets of each SZmiRNA for the random genes. We repeated this randomness analysis 10,000 times. Then, we used one sample t-test to test the significance.
miRNAs clustered in a genomic region are preferentially co-expressed and miRNAs in gene region are usually co-expressed with their host genes, presumably due to being part of the same transcription unit [58, 59, 66, 67]. After comparing the miRNA cluster results of 3 kb, 5 kb, and 10 kb, we used a 5 kb maximum inter-miRNA distance as the miRNA cluster criteria, which is the same as in Xu and Wong . Putative promoter regions of intergenic miRNAs were estimated up to several kb upstream from the miRNA precursors [13, 69]. Here, we used 5 kb upstream of the host gene, miRNA precursor or miRNA cluster as the putative promoter region for miRNA in a genic region, intergenic region or miRNA cluster, respectively. Similar FFL results were found when we set a 1 kb promoter region (data not shown).
Because TFBS is always short, i.e., a 6-8 bp core sequence, prediction of TFBS in a single species may have a much higher false positive rate than that based on conservation across multiple species. We retrieved predicted TFBS information from the UCSC genome browser (hg18 genome assembly) and required TFBSs to be conserved among humans, mice and rats. To further reduce the false positive prediction, we used Z score of 2.33 as a cutoff for high quality TFBSs. A TFBS was considered associated with a target gene when it was in the gene's promoter region and its Z score was >2.33.
Feed-forward loops (FFLs) and statistics tests
We analyzed FFLs for TFBSs, miRNAs and schizophrenia genes according to the procedure in Figure 1. Some TFBSs might overlap on their locations, could be bound by the same TF, or could be combined due to similar sequences. We manually merged those TFBSs to reduce redundancy.
Two methods were used to evaluate if the FFLs observed in the set of TFBSs, SZmiRNAs and SZGenes were significantly enriched from genome background. First, for the same SZGenes, we used Fisher's exact test to compare the observed FFLs from SZmiRNAs with those from brain miRNAs or non-brain miRNAs. Second, we ran randomization processes using the method in Shalgi et al . In each run, we extracted the same number of random miRNA target pairs out of all predicted target pairs of the SZmiRNAs and identified TFBSs in the promoter of these random miRNA target genes, then calculated the number of FFLs. We repeated this 10,000 times, and set the p-value as the proportion of the random results that had no less than the number of FFLs observed in the set of SZmiRNAs and SZGenes.
Network and pathway analysis
We used the Core Analysis tool in the Ingenuity Pathway Analysis (IPA) system  to analyze networks and pathways for a set of genes. We set p-value < 0.01 as the cutoff for enriched significant pathways identified by IPA. Networks were presented with Cytoscape software (version 2.6.0) . In the miRNA-TF mediated network, when a schizophrenia gene was regulated by at least 3 TFs and at least 3 miRNAs, we defined it a core gene (hub gene). Similarly, when a miRNA regulated at least 3 SZGenes and was also regulated by at least 3 TFs, we defined it a core miRNA. Enriched GO terms for a set of genes were examined using the DAVID bioinformatics web server .
We thank Jeff Ewers for critical reading and improving the manuscript. This work was supported by grants from National Institute of Health (AA017437 and AA017828), Thomas F. and Kate Miller Jeffress Memorial Trust Fund, and NARSAD Young Investigator Award to ZZ.
- Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J: Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 2007, 20: 687-702. 10.1159/000110430View ArticlePubMedGoogle Scholar
- Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R, Barnes MR, Larminie C, Jones N, Lennon M, et al.: Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry. 2009, 14: 1083-1094. 10.1038/mp.2009.18View ArticlePubMedGoogle Scholar
- Bray NJ: Gene expression in the etiology of schizophrenia. Schizophr Bull. 2008, 34: 412-418. 10.1093/schbul/sbn013PubMed CentralView ArticlePubMedGoogle Scholar
- Sethupathy P, Collins FS: MicroRNA target site polymorphisms and human disease. Trends Genet. 2008, 24: 489-497. 10.1016/j.tig.2008.07.004View ArticlePubMedGoogle Scholar
- Kuss AW, Chen W: MicroRNAs in brain function and disease. Curr Neurol Neurosci Rep. 2008, 8: 190-197. 10.1007/s11910-008-0031-0View ArticlePubMedGoogle Scholar
- Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM: microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8: R27- 10.1186/gb-2007-8-2-r27PubMed CentralView ArticlePubMedGoogle Scholar
- Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I, Cairns MJ: Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet. 2008, 17: 1156-1168. 10.1093/hmg/ddn005View ArticlePubMedGoogle Scholar
- Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, et al.: Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE. 2007, 2: e873- 10.1371/journal.pone.0000873PubMed CentralView ArticlePubMedGoogle Scholar
- Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, Wan X, Pavlidis P, Mills AA, Karayiorgou M, Gogos JA: Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet. 2008, 40: 751-760. 10.1038/ng.138View ArticlePubMedGoogle Scholar
- Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S: A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet. 2008, 17: 3030-3042. 10.1093/hmg/ddn201PubMed CentralView ArticlePubMedGoogle Scholar
- Kocerha J, Faghihi MA, Lopez-Toledano MA, Huang J, Ramsey AJ, Caron MG, Sales N, Willoughby D, Elmen J, Hansen HF, et al.: MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci USA. 2009, 106: 3507-3512. 10.1073/pnas.0805854106PubMed CentralView ArticlePubMedGoogle Scholar
- Coyle JT: MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proc Natl Acad Sci USA. 2009, 106: 2975-2976. 10.1073/pnas.0813321106PubMed CentralView ArticlePubMedGoogle Scholar
- Saini HK, Griffiths-Jones S, Enright AJ: Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA. 2007, 104: 17719-17724. 10.1073/pnas.0703890104PubMed CentralView ArticlePubMedGoogle Scholar
- Shalgi R, Lieber D, Oren M, Pilpel Y: Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol. 2007, 3: e131- 10.1371/journal.pcbi.0030131PubMed CentralView ArticlePubMedGoogle Scholar
- Tsang J, Zhu J, van Oudenaarden A: MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell. 2007, 26: 753-767. 10.1016/j.molcel.2007.05.018PubMed CentralView ArticlePubMedGoogle Scholar
- Martinez NJ, Ow MC, Barrasa MI, Hammell M, Sequerra R, Doucette-Stamm L, Roth FP, Ambros VR, Walhout AJ: A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity. Genes Dev. 2008, 22: 2535-2549. 10.1101/gad.1678608PubMed CentralView ArticlePubMedGoogle Scholar
- Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ: A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68: 7846-7854. 10.1158/0008-5472.CAN-08-1942View ArticlePubMedGoogle Scholar
- Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A: A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007, 317: 1220-1224. 10.1126/science.1140481PubMed CentralView ArticlePubMedGoogle Scholar
- Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P: An E2F/miR-20a autoregulatory feedback loop. J Biol Chem. 2007, 282: 2135-2143. 10.1074/jbc.M608939200View ArticlePubMedGoogle Scholar
- Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L: Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008, 40: 827-834. 10.1038/ng.171View ArticlePubMedGoogle Scholar
- Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V, Straub RE, Weinberger DR, Kleinman JE: Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet. 2008, 17: 2293-2309. 10.1093/hmg/ddn130PubMed CentralView ArticlePubMedGoogle Scholar
- Ingenuity Systems. http://www.ingenuity.com/
- Negishi M, Oinuma I, Katoh H: Plexins: axon guidance and signal transduction. Cell Mol Life Sci. 2005, 62: 1363-1371. 10.1007/s00018-005-5018-2View ArticlePubMedGoogle Scholar
- Klein R: Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat Neurosci. 2009, 12: 15-20. 10.1038/nn.2231View ArticlePubMedGoogle Scholar
- De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, et al.: A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science. 2006, 312: 1215-1217. 10.1126/science.1126431View ArticlePubMedGoogle Scholar
- Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, et al.: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003, 35: 341-348. 10.1038/ng1267View ArticlePubMedGoogle Scholar
- Sullivan PF, Lin D, Tzeng JY, Oord van den E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, et al.: Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 2008, 13: 570-584. 10.1038/mp.2008.25PubMed CentralView ArticlePubMedGoogle Scholar
- Jia P, Sun J, Guo A, Zhao Z: SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry. 2010Google Scholar
- O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM: The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999, 22: 167-173. 10.1016/S0166-2236(98)01343-5View ArticlePubMedGoogle Scholar
- Eldredge LC, Gao XM, Quach DH, Li L, Han X, Lomasney J, Tourtellotte WG: Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice. Development. 2008, 135: 2949-2957. 10.1242/dev.023960PubMed CentralView ArticlePubMedGoogle Scholar
- Li L, Yun SH, Keblesh J, Trommer BL, Xiong H, Radulovic J, Tourtellotte WG: Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol Cell Neurosci. 2007, 35: 76-88. 10.1016/j.mcn.2007.02.004PubMed CentralView ArticlePubMedGoogle Scholar
- Li L, Carter J, Gao X, Whitehead J, Tourtellotte WG: The neuroplasticity-associated arc gene is a direct transcriptional target of early growth response (Egr) transcription factors. Mol Cell Biol. 2005, 25: 10286-10300. 10.1128/MCB.25.23.10286-10300.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Roberts DS, Raol YH, Bandyopadhyay S, Lund IV, Budreck EC, Passini MA, Wolfe JH, Brooks-Kayal AR, Russek SJ: Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression. Proc Natl Acad Sci USA. 2005, 102: 11894-11899. 10.1073/pnas.0501434102PubMed CentralView ArticlePubMedGoogle Scholar
- Roberts DS, Hu Y, Lund IV, Brooks-Kayal AR, Russek SJ: Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons. J Biol Chem. 2006, 281: 29431-29435. 10.1074/jbc.C600167200View ArticlePubMedGoogle Scholar
- Gallitano-Mendel A, Izumi Y, Tokuda K, Zorumski CF, Howell MP, Muglia LJ, Wozniak DF, Milbrandt J: The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience. 2007, 148: 633-643. 10.1016/j.neuroscience.2007.05.050View ArticlePubMedGoogle Scholar
- Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, Leonard S: Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res. 2005, 139: 317-332. 10.1016/j.molbrainres.2005.06.006View ArticlePubMedGoogle Scholar
- Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Aruga J, Minabe Y, Tonegawa S, Yoshikawa T: Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci USA. 2007, 104: 2815-2820. 10.1073/pnas.0610765104PubMed CentralView ArticlePubMedGoogle Scholar
- Gallitano-Mendel A, Wozniak DF, Pehek EA, Milbrandt J: Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology. 2008, 33: 1266-1275. 10.1038/sj.npp.1301505PubMed CentralView ArticlePubMedGoogle Scholar
- Santos AR, Duarte CB: Validation of internal control genes for expression studies: effects of the neurotrophin BDNF on hippocampal neurons. J Neurosci Res. 2008, 86: 3684-3692. 10.1002/jnr.21796View ArticlePubMedGoogle Scholar
- Jacobson C, Duggan D, Fischbach G: Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle. Proc Natl Acad Sci USA. 2004, 101: 12218-12223. 10.1073/pnas.0404240101PubMed CentralView ArticlePubMedGoogle Scholar
- Calella AM, Nerlov C, Lopez RG, Sciarretta C, von Bohlen , Halbach O, Bereshchenko O, Minichiello L: Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription. Neural Develop. 2007, 2: 4-10.1186/1749-8104-2-4.PubMed CentralView ArticleGoogle Scholar
- Ehrengruber MU, Muhlebach SG, Sohrman S, Leutenegger CM, Lester HA, Davidson N: Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene. 2000, 258: 63-69. 10.1016/S0378-1119(00)00445-5View ArticlePubMedGoogle Scholar
- Gao X, Daugherty RL, Tourtellotte WG: Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators. Mol Cell Neurosci. 2007, 36: 501-514. 10.1016/j.mcn.2007.08.013PubMed CentralView ArticlePubMedGoogle Scholar
- Dechant G, Barde YA: The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci. 2002, 5: 1131-1136. 10.1038/nn1102-1131View ArticlePubMedGoogle Scholar
- Mittelstadt PR, Ashwell JD: Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol. 1998, 18: 3744-3751.PubMed CentralView ArticlePubMedGoogle Scholar
- Sheng M, Kim MJ: Postsynaptic signaling and plasticity mechanisms. Science. 2002, 298: 776-780. 10.1126/science.1075333View ArticlePubMedGoogle Scholar
- Yamagata K, Kaufmann WE, Lanahan A, Papapavlou M, Barnes CA, Andreasson KI, Worley PF: Egr3/Pilot, a zinc finger transcription factor, is rapidly regulated by activity in brain neurons and colocalizes with Egr1/zif268. Learn Mem. 1994, 1: 140-152.PubMedGoogle Scholar
- Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S: Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA. 2003, 100: 8993-8998. 10.1073/pnas.1432927100PubMed CentralView ArticlePubMedGoogle Scholar
- Nguyen T, Di Giovanni S: NFAT signaling in neural development and axon growth. Int J Dev Neurosci. 2008, 26: 141-145. 10.1016/j.ijdevneu.2007.10.004PubMed CentralView ArticlePubMedGoogle Scholar
- Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M, Crabtree GR: Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell. 2003, 113: 657-670. 10.1016/S0092-8674(03)00390-8View ArticlePubMedGoogle Scholar
- Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD, Glimcher LH: Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity. 2000, 12: 293-300. 10.1016/S1074-7613(00)80182-XView ArticlePubMedGoogle Scholar
- Mangan S, Alon U: Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci USA. 2003, 100: 11980-11985. 10.1073/pnas.2133841100PubMed CentralView ArticlePubMedGoogle Scholar
- Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, et al.: p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol. 2008, 4: 229- 10.1038/msb.2008.65PubMed CentralView ArticlePubMedGoogle Scholar
- Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH, Rosner MR: A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res. 2009, 69: 65-74. 10.1158/0008-5472.CAN-08-0377PubMed CentralView ArticlePubMedGoogle Scholar
- Inoue A, Omoto Y, Yamaguchi Y, Kiyama R, Hayashi SI: Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J Mol Endocrinol. 2004, 32: 649-661. 10.1677/jme.0.0320649View ArticlePubMedGoogle Scholar
- Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI: MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc). 2007, 72: 578-582. 10.1134/S0006297907050161View ArticleGoogle Scholar
- Zhang R, Su B: MicroRNA regulation and the variability of human cortical gene expression. Nucleic Acids Res. 2008, 36: 4621-4628. 10.1093/nar/gkn431PubMed CentralView ArticlePubMedGoogle Scholar
- Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al.: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007, 129: 1401-1414. 10.1016/j.cell.2007.04.040PubMed CentralView ArticlePubMedGoogle Scholar
- Liang Y, Ridzon D, Wong L, Chen C: Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007, 8: 166- 10.1186/1471-2164-8-166PubMed CentralView ArticlePubMedGoogle Scholar
- Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36: D154-158. 10.1093/nar/gkm952PubMed CentralView ArticlePubMedGoogle Scholar
- Sun J, Jia P, Fanous AH, Webb BT, Oord van den EJCG, Chen X, Bukszar J, Kendler KS, Zhao Z: A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases - schizophrenia as a case. Bioinformatics. 2009, 25: 2595-2602. 10.1093/bioinformatics/btp428PubMed CentralView ArticlePubMedGoogle Scholar
- Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z: Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet. 2008, 147B: 1173-1181. 10.1002/ajmg.b.30743View ArticlePubMedGoogle Scholar
- Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature. 2008, 455: 58-63. 10.1038/nature07228View ArticlePubMedGoogle Scholar
- Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP: The impact of microRNAs on protein output. Nature. 2008, 455: 64-71. 10.1038/nature07242PubMed CentralView ArticlePubMedGoogle Scholar
- TargetScan: Prediction of microRNA targets. http://www.targetscan.org/vert_42/
- Baskerville S, Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. Rna. 2005, 11: 241-247. 10.1261/rna.7240905PubMed CentralView ArticlePubMedGoogle Scholar
- Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14: 1902-1910. 10.1101/gr.2722704PubMed CentralView ArticlePubMedGoogle Scholar
- Xu J, Wong C: A computational screen for mouse signaling pathways targeted by microRNA clusters. Rna. 2008, 14: 1276-1283. 10.1261/rna.997708PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou X, Ruan J, Wang G, Zhang W: Characterization and identification of microRNA core promoters in four model species. PLoS Comput Biol. 2007, 3: e37- 10.1371/journal.pcbi.0030037PubMed CentralView ArticlePubMedGoogle Scholar
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303PubMed CentralView ArticlePubMedGoogle Scholar
- DAVID Bioinformatics Resources. http://david.abcc.ncifcrf.gov/
- Hu Y, Russek SJ: BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J Neurochem. 2008, 105: 1-17. 10.1111/j.1471-4159.2008.05237.xView ArticlePubMedGoogle Scholar
- Patapoutian A, Reichardt LF: Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001, 11: 272-280. 10.1016/S0959-4388(00)00208-7View ArticlePubMedGoogle Scholar
- Mei L, Xiong WC: Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008, 9: 437-452. 10.1038/nrn2392PubMed CentralView ArticlePubMedGoogle Scholar